Genesee Capital Advisors’s Hims & Hers Health HIMS Stock Holding History

Genesee Capital Advisors’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.23M	Sell	35,376 -3,774	-10%	-$101K	0.39%	54
2026 Q1	$813K	Sell	39,150 -188	-0.5%	-$4.44K	0.34%	65
2025 Q4	$1.28M	Buy	39,338 +2,264	+6%	+$97K	0.51%	46
2025 Q3	$2.1M	Sell	37,074 -625	-2%	-$32K	0.91%	24
2025 Q2	$1.88M	Buy	37,699 +3,013	+9%	+$136K	0.84%	28
2025 Q1	$1.02M	Sell	34,686 -2,063	-6%	-$76.6K	0.51%	43
2024 Q4	$889K	Buy	+36,749	New	+$910K	0.41%	56

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Genesee Capital Advisors's HIMS Position: Q2 2026 in Review

Genesee Capital Advisors reduced its Hims & Hers Health (HIMS) stake by 9.6% in Q2 2026, selling an estimated $101K and leaving 35,376 shares worth $1.23M. The position accounts for 0.39% of the portfolio, ranked #54.

Genesee Capital Advisors first reported a position in HIMS in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.1M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Genesee Capital Advisors held 35,376 shares of Hims & Hers Health worth $1.23M as of Q2 2026.
Genesee Capital Advisors sold 3,774 Hims & Hers Health shares in Q2 2026, an estimated $101K.
Hims & Hers Health made up 0.39% of Genesee Capital Advisors's portfolio in Q2 2026, its #54 holding.
Genesee Capital Advisors first reported a position in Hims & Hers Health in Q4 2024 and has held it in 7 quarters since.
Genesee Capital Advisors's Hims & Hers Health position peaked at $2.1M in Q3 2025.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Genesee Capital Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.